Tilray is a global leader in medical cannabis research, cultivation, processing and distribution. We aspire to lead, legitimise and define the future of our industry by building the world’s most trusted cannabis company.
A proud pioneer, we are the first GMP-certified medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers on five continents.
Tilray’s experience is unmatched worldwide. Our team of 240+ professionals in seven countries serves thousands of patients around the globe. Our 60,000-square foot flagship cultivation facility in British Columbia, Canada, is among the most advanced in the world.
The Tilray European Union Campus, centred on the Biocant Life Sciences and Biotechnology Research Park in Cantanhede, Portugal, is a €20 million investment to further Tilray’s position as Europe’s leading supplier of GMP medical cannabis extract and dried products.
We are committed to scientific research that leads to an improved quality of life, partnering
... read more at: https://www.healtheuropa.eu/medical-cannabis-research-leader/87243/